10x Genomics, Inc. Class A Common Stock (TXG) is a publicly traded Healthcare sector company. As of September 1, 2026, TXG trades at $61.23 with a market cap of $8.02B and a P/E ratio of -103.77. TXG moved -5.10% today. Year to date, TXG is +277.31%; over the trailing twelve months it is +330.95%. Its 52-week range spans $6.78 to $66.94. Analyst consensus is buy with an average price target of $50.36. Rallies surfaces TXG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
10x Genomics, Inc. Class A Common Stock (TXG) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TXG moved -5.10% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $61.23 |
| Market Cap | $8.02B |
| P/E Ratio | -103.77 |
| EPS | $-0.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $66.94 |
| 52-Week Low | $6.78 |
| Volume | 2.08M |
| Avg Volume | 0 |
| Revenue (TTM) | $616.91M |
| Net Income | $-75.13M |
| Gross Margin | 70.03% |
13 analysts cover TXG: 0 strong buy, 6 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $50.36.